English

ADVANCED TISSUE SCIENCES INC

EDGAR

Filing (3) · filed 2003-03-31

42 filing records in this dataset, filed from 1995-05-12 to 2003-03-31. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

5.07 million USD

2002-09-30 · USD

Exact inputs and evidence

Revenue: 5070000 USD Source

Operating margin

-196.19%

2002-09-30 · %

Exact inputs and evidence

Operating Income: -9947000 USD Source
Revenue: 5070000 USD Source

Operating cash flow

-5.61 million USD

2002-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -15054000 USD Source
Operating Cash Flow: -9447000 USD Source

Cash and cash equivalents: 3.05 million USD 2002-09-30 Source
Exact value

3050000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

24.2 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Revenue: 28940000 USD · 2001-01-01 – 2001-12-31 Source
Revenue: 20750000 USD · 2001-01-01 – 2001-09-30 Source
Revenue: 4754000 USD · 2002-01-01 – 2002-03-31 Source
Revenue: 6220000 USD · 2002-04-01 – 2002-06-30 Source
Revenue: 5070000 USD · 2002-07-01 – 2002-09-30 Source

Net income

-35.8 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Net income: -28373000 USD · 2001-01-01 – 2001-12-31 Source
Net income: -19298000 USD · 2001-01-01 – 2001-09-30 Source
Net income: -7737000 USD · 2002-01-01 – 2002-03-31 Source
Net income: -8573000 USD · 2002-04-01 – 2002-06-30 Source
Net income: -10408000 USD · 2002-07-01 – 2002-09-30 Source

Operating cash flow

-17.7 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Operating cash flow: -17846000 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: -15250000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -4728000 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -9447000 USD · 2002-01-01 – 2002-06-30 Source
Operating cash flow: -4728000 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -15054000 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -9447000 USD · 2002-01-01 – 2002-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2003-03-31.

Financial data available through: 2001-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2001-12-31
Operating income: 7 of 11 periods available· newest 2001-12-31
Net income: 9 of 11 periods available· newest 2001-12-31
Operating cash flow: 9 of 11 periods available· newest 2001-12-31
capital expenditure: No compatible figures in this window
Total assets: 8 of 11 periods available· newest 2001-12-31
Total liabilities: 6 of 11 periods available· newest 2001-12-31
Current assets: 8 of 11 periods available· newest 2001-12-31
Current liabilities: 8 of 11 periods available· newest 2001-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2001-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+14.5%

Prior period

USD 25.27 million

2000-01-01 – 2000-12-31
Current period

USD 28.94 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

28940000 − 25271000 = 3669000 USD

25271000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
28940000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ADVANCED TISSUE SCIENCES INC · 2001-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Year-over-year change in Revenue: 3669000 USD Concept: fundies:Revenue Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 28940000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4142 Input fundies:Revenue: 25271000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4142
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 3.8 million

Prior period

−USD 24.57 million

2000-01-01 – 2000-12-31
Current period

−USD 28.37 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-28373000 − -24571000 = -3802000 USD

-24571000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-28373000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ADVANCED TISSUE SCIENCES INC · 2001-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Year-over-year change in Net income: -3802000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -28373000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4199 Input fundies:NetIncome: -24571000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4199
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 3.56 million

Prior period

−USD 14.29 million

2000-01-01 – 2000-12-31
Current period

−USD 17.85 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-17846000 − -14286000 = -3560000 USD

-14286000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-17846000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ADVANCED TISSUE SCIENCES INC · 2001-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Year-over-year change in Operating cash flow: -3560000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -17846000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4218 Input fundies:OperatingCashFlow: -14286000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4218
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2001 2001-01-01 – 2001-12-31

Revenue USD 28.94 million 100% of revenue
Cost of revenue USD 8.34 million 29% of revenue
Operating expenses USD 20.3 million 70% of revenue
Other operating costs Derived USD 28.96 million 100% of revenue
Operating income −USD 28.65 million −99% of revenue
Tax, interest and other Derived −USD 281,000 −1% of revenue
Net income −USD 28.37 million −98% of revenue

Cash

Operating cash flow −USD 17.85 million −62% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1993 Not shown: operating income or net income is not reported.
1994 Not shown: operating income or net income is not reported.
1995 Operating loss: operating costs were 782% of revenue.
1996 Operating loss: operating costs were 265% of revenue.
1997 Operating loss: operating costs were 377% of revenue.
1998 Operating loss: operating costs were 306% of revenue.
1999 Operating loss: operating costs were 148% of revenue.
2000 Operating loss: operating costs were 202% of revenue.
2001 Operating loss: operating costs were 199% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1993 1993-01-01 – 1993-12-31	5866000	Unavailable	Unavailable	Unavailable	-17691000	Unavailable	Source 1993-01-01 – 1993-12-31: 5866000 USD Inspect Revenue Open source 1993-01-01 – 1993-12-31: -17691000 USD Inspect Net Income Open source 1993-01-01 – 1993-12-31: -13329000 USD Inspect Operating Cash Flow Open source
1994 1994-01-01 – 1994-12-31	3215000	Unavailable	Unavailable	Unavailable	-22775000	Unavailable	Source 1994-01-01 – 1994-12-31: 3215000 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -22775000 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -22605000 USD Inspect Operating Cash Flow Open source
1995 1995-01-01 – 1995-12-31	3565000	27869000 Derived	-24304000	-1179000 Derived	-23125000	Unavailable	Source 1995-01-01 – 1995-12-31: 3565000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -24304000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -23125000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -21252000 USD Inspect Operating Cash Flow Open source
1996 1996-01-01 – 1996-12-31	14592000	38706000 Derived	-24114000	-1713000 Derived	-22401000	Unavailable	Source 1996-01-01 – 1996-12-31: 14592000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -24114000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -22401000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -18546000 USD Inspect Operating Cash Flow Open source
1997 1997-01-01 – 1997-12-31	13151000	49615000 Derived	-36464000	-375000 Derived	-36089000	Unavailable	Source 1997-01-01 – 1997-12-31: 13151000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -36464000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -36089000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -23454000 USD Inspect Operating Cash Flow Open source
1998 1998-01-01 – 1998-12-31	20481000	62743000 Derived	-42262000	1023000 Derived	-43285000	Unavailable	Source 1998-01-01 – 1998-12-31: 20481000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -42262000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -43285000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -21655000 USD Inspect Operating Cash Flow Open source
1999 1999-01-01 – 1999-12-31	42803000	63424000 Derived	-20621000	685000 Derived	-21306000	Unavailable	Source 1999-01-01 – 1999-12-31: 42803000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -20621000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -21306000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 12336000 USD Inspect Operating Cash Flow Open source
2000 2000-01-01 – 2000-12-31	25271000	50981000 Derived	-25710000	-1139000 Derived	-24571000	Unavailable	Source 2000-01-01 – 2000-12-31: 25271000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -25710000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -24571000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -14286000 USD Inspect Operating Cash Flow Open source
2001 2001-01-01 – 2001-12-31	28940000	57594000 Derived	-28654000	-281000 Derived	-28373000	Unavailable	Source 2001-01-01 – 2001-12-31: 28940000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -28654000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -28373000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -17846000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 28.9M 2001

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Revenue	5866000	Revenue: 5866000 Open source
19941994-12-31	Revenue	3215000	Revenue: 3215000 Open source
19951995-12-31	Revenue	3565000	Revenue: 3565000 Open source
19961996-12-31	Revenue	14592000	Revenue: 14592000 Open source
19971997-12-31	Revenue	13151000	Revenue: 13151000 Open source
19981998-12-31	Revenue	20481000	Revenue: 20481000 Open source
19991999-12-31	Revenue	42803000	Revenue: 42803000 Open source
20002000-12-31	Revenue	25271000	Revenue: 25271000 Open source
20012001-12-31	Revenue	28940000	Revenue: 28940000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

14.5% 2001

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19931993-12-31	Year over year	No prior comparable period	Revenue: 5866000 Open source
19941994-12-31	Year over year	-45.2%	Revenue: 3215000 Open source Revenue: 5866000 Open source
19951995-12-31	Year over year	10.9%	Revenue: 3565000 Open source Revenue: 3215000 Open source
19961996-12-31	Year over year	309.3%	Revenue: 14592000 Open source Revenue: 3565000 Open source
19971997-12-31	Year over year	-9.9%	Revenue: 13151000 Open source Revenue: 14592000 Open source
19981998-12-31	Year over year	55.7%	Revenue: 20481000 Open source Revenue: 13151000 Open source
19991999-12-31	Year over year	109%	Revenue: 42803000 Open source Revenue: 20481000 Open source
20002000-12-31	Year over year	-41%	Revenue: 25271000 Open source Revenue: 42803000 Open source
20012001-12-31	Year over year	14.5%	Revenue: 28940000 Open source Revenue: 25271000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -99% 2001

Net margin -98% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Operating margin	Not reported	Revenue: 5866000 Open source
1994-12-31	Operating margin	Not reported	Revenue: 3215000 Open source
19951995-12-31	Operating margin	-681.7%	Operating Income: -24304000 Open source Revenue: 3565000 Open source
19961996-12-31	Operating margin	-165.3%	Operating Income: -24114000 Open source Revenue: 14592000 Open source
19971997-12-31	Operating margin	-277.3%	Operating Income: -36464000 Open source Revenue: 13151000 Open source
19981998-12-31	Operating margin	-206.3%	Operating Income: -42262000 Open source Revenue: 20481000 Open source
19991999-12-31	Operating margin	-48.2%	Operating Income: -20621000 Open source Revenue: 42803000 Open source
20002000-12-31	Operating margin	-101.7%	Operating Income: -25710000 Open source Revenue: 25271000 Open source
20012001-12-31	Operating margin	-99%	Operating Income: -28654000 Open source Revenue: 28940000 Open source
19931993-12-31	Net margin	-301.6%	Net Income: -17691000 Open source Revenue: 5866000 Open source
19941994-12-31	Net margin	-708.4%	Net Income: -22775000 Open source Revenue: 3215000 Open source
19951995-12-31	Net margin	-648.7%	Net Income: -23125000 Open source Revenue: 3565000 Open source
19961996-12-31	Net margin	-153.5%	Net Income: -22401000 Open source Revenue: 14592000 Open source
19971997-12-31	Net margin	-274.4%	Net Income: -36089000 Open source Revenue: 13151000 Open source
19981998-12-31	Net margin	-211.3%	Net Income: -43285000 Open source Revenue: 20481000 Open source
19991999-12-31	Net margin	-49.8%	Net Income: -21306000 Open source Revenue: 42803000 Open source
20002000-12-31	Net margin	-97.2%	Net Income: -24571000 Open source Revenue: 25271000 Open source
20012001-12-31	Net margin	-98%	Net Income: -28373000 Open source Revenue: 28940000 Open source
19931993-12-31	Free cash flow margin	Not reported	Revenue: 5866000 Open source Operating Cash Flow: -13329000 Open source
19941994-12-31	Free cash flow margin	Not reported	Revenue: 3215000 Open source Operating Cash Flow: -22605000 Open source
19951995-12-31	Free cash flow margin	Not reported	Revenue: 3565000 Open source Operating Cash Flow: -21252000 Open source
19961996-12-31	Free cash flow margin	Not reported	Revenue: 14592000 Open source Operating Cash Flow: -18546000 Open source
19971997-12-31	Free cash flow margin	Not reported	Revenue: 13151000 Open source Operating Cash Flow: -23454000 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 20481000 Open source Operating Cash Flow: -21655000 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 42803000 Open source Operating Cash Flow: 12336000 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 25271000 Open source Operating Cash Flow: -14286000 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 28940000 Open source Operating Cash Flow: -17846000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -17.8M 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Operating cash flow	-13329000	Operating Cash Flow: -13329000 Open source
19941994-12-31	Operating cash flow	-22605000	Operating Cash Flow: -22605000 Open source
19951995-12-31	Operating cash flow	-21252000	Operating Cash Flow: -21252000 Open source
19961996-12-31	Operating cash flow	-18546000	Operating Cash Flow: -18546000 Open source
19971997-12-31	Operating cash flow	-23454000	Operating Cash Flow: -23454000 Open source
19981998-12-31	Operating cash flow	-21655000	Operating Cash Flow: -21655000 Open source
19991999-12-31	Operating cash flow	12336000	Operating Cash Flow: 12336000 Open source
20002000-12-31	Operating cash flow	-14286000	Operating Cash Flow: -14286000 Open source
20012001-12-31	Operating cash flow	-17846000	Operating Cash Flow: -17846000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Free cash flow	Unavailable	Operating Cash Flow: -13329000 Open source
19941994-12-31	Free cash flow	Unavailable	Operating Cash Flow: -22605000 Open source
19951995-12-31	Free cash flow	Unavailable	Operating Cash Flow: -21252000 Open source
19961996-12-31	Free cash flow	Unavailable	Operating Cash Flow: -18546000 Open source
19971997-12-31	Free cash flow	Unavailable	Operating Cash Flow: -23454000 Open source
19981998-12-31	Free cash flow	Unavailable	Operating Cash Flow: -21655000 Open source
19991999-12-31	Free cash flow	Unavailable	Operating Cash Flow: 12336000 Open source
20002000-12-31	Free cash flow	Unavailable	Operating Cash Flow: -14286000 Open source
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: -17846000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

32.1% 2001

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Liabilities / assets	Not reported	No source recorded
1994-12-31	Liabilities / assets	Not reported	Total Assets: 33426000 Open source
1995-12-31	Liabilities / assets	Not reported	Total Assets: 31141000 Open source
19961996-12-31	Liabilities / assets	14.4%	Total Liabilities: 8121000 Open source Total Assets: 56501000 Open source
19971997-12-31	Liabilities / assets	72.3%	Total Liabilities: 36494000 Open source Total Assets: 50460000 Open source
19981998-12-31	Liabilities / assets	67.5%	Total Liabilities: 36458000 Open source Total Assets: 53985000 Open source
19991999-12-31	Liabilities / assets	55.4%	Total Liabilities: 32923000 Open source Total Assets: 59386000 Open source
20002000-12-31	Liabilities / assets	39.4%	Total Liabilities: 23304000 Open source Total Assets: 59106000 Open source
20012001-12-31	Liabilities / assets	32.1%	Total Liabilities: 19899000 Open source Total Assets: 61922000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.16× 2001

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Current assets / current liabilities	Not reported	No source recorded
19941994-12-31	Current assets / current liabilities	4.78×	Current Assets: 24077000 Open source Current Liabilities: 5040000 Open source
19951995-12-31	Current assets / current liabilities	4.02×	Current Assets: 20963000 Open source Current Liabilities: 5216000 Open source
19961996-12-31	Current assets / current liabilities	5.46×	Current Assets: 44044000 Open source Current Liabilities: 8060000 Open source
19971997-12-31	Current assets / current liabilities	2.33×	Current Assets: 23124000 Open source Current Liabilities: 9908000 Open source
19981998-12-31	Current assets / current liabilities	3.44×	Current Assets: 28830000 Open source Current Liabilities: 8388000 Open source
19991999-12-31	Current assets / current liabilities	1.45×	Current Assets: 34223000 Open source Current Liabilities: 23572000 Open source
20002000-12-31	Current assets / current liabilities	2.67×	Current Assets: 40112000 Open source Current Liabilities: 15030000 Open source
20012001-12-31	Current assets / current liabilities	3.16×	Current Assets: 44645000 Open source Current Liabilities: 14137000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1993 1993-01-01 – 1993-12-31	−USD 17.69 million Exact value Exact value: -17691000 USD 1993-01-01 – 1993-12-31: -17691000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED TISSUE SCIENCES INC · 1993-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Net Income: -17691000 USD Concept: fundies:NetIncome Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3ANetIncome&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17691000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000892569-96-000182.txt#2649 The citation records this snapshot. The page link may show a newer release later.	−USD 13.33 million Exact value Exact value: -13329000 USD 1993-01-01 – 1993-12-31: -13329000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED TISSUE SCIENCES INC · 1993-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Operating Cash Flow: -13329000 USD Concept: fundies:OperatingCashFlow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3AOperatingCashFlow&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13329000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000892569-96-000182.txt#2666 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1994 1994-01-01 – 1994-12-31	−USD 22.78 million Exact value Exact value: -22775000 USD 1994-01-01 – 1994-12-31: -22775000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED TISSUE SCIENCES INC · 1994-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Net Income: -22775000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22775000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-97-000005.txt#2753 The citation records this snapshot. The page link may show a newer release later.	−USD 22.61 million Exact value Exact value: -22605000 USD 1994-01-01 – 1994-12-31: -22605000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED TISSUE SCIENCES INC · 1994-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Operating Cash Flow: -22605000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22605000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-97-000005.txt#2766 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1995 1995-01-01 – 1995-12-31	−USD 23.13 million Exact value Exact value: -23125000 USD 1995-01-01 – 1995-12-31: -23125000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED TISSUE SCIENCES INC · 1995-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Net Income: -23125000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23125000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-98-000008.txt#3146 The citation records this snapshot. The page link may show a newer release later.	−USD 21.25 million Exact value Exact value: -21252000 USD 1995-01-01 – 1995-12-31: -21252000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED TISSUE SCIENCES INC · 1995-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Operating Cash Flow: -21252000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21252000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-98-000008.txt#3161 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1996 1996-01-01 – 1996-12-31	−USD 22.4 million Exact value Exact value: -22401000 USD 1996-01-01 – 1996-12-31: -22401000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED TISSUE SCIENCES INC · 1996-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Net Income: -22401000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22401000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-99-000024.txt#1084 The citation records this snapshot. The page link may show a newer release later.	−USD 18.55 million Exact value Exact value: -18546000 USD 1996-01-01 – 1996-12-31: -18546000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED TISSUE SCIENCES INC · 1996-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Operating Cash Flow: -18546000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18546000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-99-000024.txt#1099 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1997 1997-01-01 – 1997-12-31	−USD 36.09 million Exact value Exact value: -36089000 USD 1997-01-01 – 1997-12-31: -36089000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED TISSUE SCIENCES INC · 1997-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Net Income: -36089000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36089000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-00-000009.txt#3707 The citation records this snapshot. The page link may show a newer release later.	−USD 23.45 million Exact value Exact value: -23454000 USD 1997-01-01 – 1997-12-31: -23454000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED TISSUE SCIENCES INC · 1997-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Operating Cash Flow: -23454000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23454000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-00-000009.txt#3725 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1998-01-01 – 1998-12-31	−USD 43.29 million Exact value Exact value: -43285000 USD 1998-01-01 – 1998-12-31: -43285000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED TISSUE SCIENCES INC · 1998-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Net Income: -43285000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43285000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-01-000008.txt#3554 The citation records this snapshot. The page link may show a newer release later.	−USD 21.66 million Exact value Exact value: -21655000 USD 1998-01-01 – 1998-12-31: -21655000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED TISSUE SCIENCES INC · 1998-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Operating Cash Flow: -21655000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21655000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-01-000008.txt#3572 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1999 1999-01-01 – 1999-12-31	−USD 21.31 million Exact value Exact value: -21306000 USD 1999-01-01 – 1999-12-31: -21306000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED TISSUE SCIENCES INC · 1999-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Net Income: -21306000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21306000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4199 The citation records this snapshot. The page link may show a newer release later.	USD 12.34 million Exact value Exact value: 12336000 USD 1999-01-01 – 1999-12-31: 12336000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED TISSUE SCIENCES INC · 1999-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Operating Cash Flow: 12336000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 12336000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4218 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 24.57 million Exact value Exact value: -24571000 USD 2000-01-01 – 2000-12-31: -24571000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED TISSUE SCIENCES INC · 2000-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Net Income: -24571000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24571000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4199 The citation records this snapshot. The page link may show a newer release later.	−USD 14.29 million Exact value Exact value: -14286000 USD 2000-01-01 – 2000-12-31: -14286000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED TISSUE SCIENCES INC · 2000-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Operating Cash Flow: -14286000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14286000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4218 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2001 2001-01-01 – 2001-12-31	−USD 28.37 million Exact value Exact value: -28373000 USD 2001-01-01 – 2001-12-31: -28373000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADVANCED TISSUE SCIENCES INC · 2001-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Net Income: -28373000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28373000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4199 The citation records this snapshot. The page link may show a newer release later.	−USD 17.85 million Exact value Exact value: -17846000 USD 2001-01-01 – 2001-12-31: -17846000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADVANCED TISSUE SCIENCES INC · 2001-12-31 ADVANCED TISSUE SCIENCES INC (edgar:829549) Operating Cash Flow: -17846000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:25:32Z Snapshot: 06707ace716cc7f56e980627da7ecaed6368503cd771cf4c0022256bea68faeb Dimensions: Consolidated View: https://fundies.io/companies/edgar/829549/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17846000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/829549/0000829549-02-000018.txt#4218 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

42 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000829549, 829549, edgar:829549

ADVANCED TISSUE SCIENCES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2001 2001-01-01 – 2001-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation